AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

VALIRX PLC

AGM Information Apr 22, 2013

7998_dva_2013-04-22_e382e3a0-e44a-4a46-a39a-dd86e6810145.html

AGM Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9006C

ValiRx PLC

22 April 2013

ValiRx plc

("ValiRx" or the "Company")

Result of AGM

ValiRx (AIM: VAL), a life science company with a focus on cancer diagnostics and therapeutics for personalised medicine, announces that at the Annual General Meeting of the Company held earlier today, all resolutions were duly passed.

Enquiries:

ValiRx plc

Dr Satu Vainikka
Tel: +44 (0)20 3008 4416

www.ValiRx.com
Cairn Financial Advisers LLP (Nominated Adviser)

Liam Murray / Avi Robinson
Tel: +44 (0)20 7148 7900
Hybridan LLP (Broker)

Claire Noyce/Deepak Reddy
Tel: + 44 (0)20 7947 4350
Peckwater PT

Tarquin Edwards
Tel: +44 (0)7879 458 364

[email protected]

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGSESFSEFDSEIL

Talk to a Data Expert

Have a question? We'll get back to you promptly.